Smith & Nephew Plc
17 September 2002
17 September 2002
SMITH & NEPHEW 2002 PRELIMINARY RESULTS TIMING
Smith & Nephew, the global advanced medical devices company, today announced
that its 2002 Preliminary Results will be released on Thursday 6 February 2003.
This will coincide with the American Academy of Orthopaedic Surgeons (AAOS)
meeting in New Orleans, which many financial analysts will be attending.
The results will be released to the London and New York Stock Exchanges at 12
noon GMT, 6am US Central time.
A simultaneous analyst meeting will be held in London at 2pm GMT and in New
Orleans at 8am Central time. The presentations will be linked by satellite and
will combine an overview of the financial results with the new product update on
the orthopaedic and endoscopy businesses, which takes place each year at the
orthopaedic academy meeting. The presentations will also be webcast live via
the Internet.
Enquiries:
Angie Craig, Director of Corporate Affairs Tel: +44 (0)20 7401 7646
Smith & Nephew plc
Jonathan Birt Tel: +44 (0) 20 7831 3113
Financial Dynamics
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.